Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benjamin Martch Insider Profile
4 Followers
Benjamin Martch, Director at Mydecine Innovations Group, holds 5.11M shares in Mydecine Innovations Group (Ticker: TSE:MYCO). Most recently, Benjamin Martch ― shares of Mydecine Innovations Group on ― for an estimated value of ―.
Benjamin Martch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Benjamin Martch's holdings
Insider Roles
Director
Roles that Benjamin Martch holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Benjamin Martch
Benjamin Martch's Trading History
List of latest transactions for each holding click on a transaction to see Benjamin Martch's performance on stock
You May Also Like
Benjamin Martch insider profile FAQ
What is the percentage of profitable transactions made by Benjamin Martch?
The percentage of profitable transactions made by Benjamin Martch is ―.
What is the average return per transaction made by Benjamin Martch?
The average return per transaction made by Benjamin Martch is ―.
What stocks does Benjamin Martch hold?
Benjamin Martch holds: TSE:MYCO stocks.
What was Benjamin Martch’s latest transaction?
Benjamin Martch latest transaction was an Uninformative Buy of ―.
What was Benjamin Martch's most profitable transaction?
Benjamin Martch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Benjamin Martch's role in Mydecine Innovations Group?
Benjamin Martch's role in Mydecine Innovations Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.